Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Pediatr Infect Dis J. 2016 Dec;35(12):e370–e377. doi: 10.1097/INF.0000000000001326

Table 2.

Correlations Between Variables of Interest and Markers of Immune Activation and Exhaustion in the HIV-infected Subjects

A. % CD4+CD38+HLA-DR+1 % CD8+CD38+HLA-DR+2
Age, years R=0.36
P<0.01
R=0.39
<0.01
LDL cholesterol, mg/dL R=−0.29
P=0.01
R=−0.23
P=0.04
HDL cholesterol, mg/dL R=−0.42
P<0.01
R=−0.24
P=0.04
HIV duration, years NS R=−0.27
P=0.02
ART duration, years R=−0.33
P<0.01
R=−0.34
P<0.01
NRTI duration, years R=−0.35
P<0.01
R=−0.34
P<0.01
Current CD4 count, cells/mm3 R=−0.33
P<0.01
R=−0.33
P<0.01
% CD4+CD38+HLA-DR+ N/A R=0.71
P<0.01
% CD4+CD38+HLA-DR+PD1+ R=0.89
P<0.01
R=0.75
P<0.01
% CD8+CD38+HLA-DR+PD1+ R=0.46
P<0.01
R=0.76
P<0.01
% CD14+CD16+ R=0.26
P=0.03
NS
% CD14dimCD16+ R=−0.42
P<0.01
NS
B. % CD4+CD38+HLA-DR+PD1+3 % CD8+CD38+HLA-DR+PD1+4
Age, years R=0.48
P<0.01
R=0.24
P=0.03
LDL cholesterol, mg/dL R=−0.24
P=0.04
NS
HDL cholesterol, mg/dL R=−0.37
<0.01
NS
ART duration, years R=−0.38
P=0.04
NS
NRTI duration, years R=−0.39
P<0.01
NS
Current CD4 count, cells/mm3 R=−0.43
P<0.01
R=−0.3
P<0.01
% CD8+CD38+HLA-DR+PD1+ N/A R=0.60
P<0.01
% CD14+CD16+ R=0.30
P=0.02
R=0.30
P<0.01
% CD14dimCD16+ R=−0.31
P<0.01
NS
C. % CD14+CD16+5 % CD14dimCD16+6 sCD147
Waist-to-hip ratio NS R=−0.25
P=0.02
NS
NNRTI duration, years NS NS R=0.33
P=0.03
Total use of EFV, years NS NS R=0.31
P=0.01
1

Mean % of CD4+ T-cells expressing CD38 and HLA-DR;

2

Mean % of CD8+ T-cells expressing CD38 and HLA-DR;

3

Mean % of CD4+ T-cells expressing CD38, HLA-DR, and PD-1;

4

Mean % of CD8+ T-cells expressing CD38, HLA-DR, and PD-1;

5

Mean % of monocytes expressing CD14+CD16+;

6

Mean % of monocytes expressing CD14dimCD16+;

7

Mean plasma concentration of sCD14

N.B. For continuous variables, Spearman Rank Correlation Coefficient was used to assess correlation. Number on top represents Spearman Correlation Coefficient and number on bottom represents P-value. CD4 nadir also tested but did not have any significant relationships. For each correlation between two immune activation/exhaustion markers, the inverse correlation is also true, but for simplicity, is listed only once.

NS, not significant; LDL, low density lipoprotein; HDL, high-density lipoprotein; ART, antiretroviral therapy; NRTI, nucleoside analogue reverse transcriptase inhibitor; N/A, not applicable; sCD14, soluble CD14; NNRTI, non-nucleoside analogue reverse transcriptase inhibitor; EFV, efavirenz